Atrandi Biosciences, a life sciences company pioneering next-generation single-cell analysis technology, today announced a $25 million Series A funding round led by Lux Capital, with participation ...

Some of the funds will be used to develop multiomics solutions based on Atrandi's proprietary technology for single-cell ...

Related: See Varda Space's private in-space manufacturing capsule's historic return to Earth in photos "Research in life sciences, specifically for monoclonal antibodies, stem cells, organoids and ...

This capsule contains the viral payload. And for successful infection, it has to ultimately open up and release the viral genetic information into the host cell. In their work, the groups of ...

and he observed that these bacteria had the smooth capsules characteristic of the S strain. Based on these observations, Griffith hypothesized that a chemical component from the virulent S cells ...